COMMUNIQUÉS West-GlobeNewswire

Crescent Biopharma Announces Grants of Inducement Awards
06/03/2026
WALTHAM, Mass., March 06, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies [...]
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06/03/2026
PRINCETON, N.J., March 06, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, [...]
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06/03/2026
BRISBANE, Calif., March 06, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on March 3, 2026, the Compensation Committee of the Board of Directors (Compensation Committee) of Vera [...]
Spyre Therapeutics Announces Grants of Inducement Awards
06/03/2026
WALTHAM, Mass., March 06, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations [...]
Harvard Bioscience Announces Reverse Stock Split
06/03/2026
Harvard Bioscience’s common stock is expected to begin trading on a post-split adjusted basis on March 16, 2026 HOLLISTON, Mass., March 06, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company [...]
CAMP4 to Participate in Upcoming Investor Conferences
06/03/2026
CAMBRIDGE, Mass., March 06, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting [...]
Tris Pharma Announces Positive Debut Data from Phase 3 ALLEVIATE-1 and 2 Trials Evaluating Cebranopadol in Acute Pain at AAPM PainConnect 2026 Annual Meeting
06/03/2026
Cebranopadol is an investigational first-of-its kind dual NOP/MOP receptor (NMR) agonist which uses a novel approach of activating NOP and MOP receptors to work synergistically to modulate pain In both ALLEVIATE trials [...]
Dermalogic Laser Center Launches New, Upgraded Website
06/03/2026
The New Jersey Practice Has Unveiled Their New Site This Winter for an Enhanced User Experience HAMMONTON, N.J., March 06, 2026 (GLOBE NEWSWIRE) -- Dermalogic Laser Center, a renowned aesthetic practice in Hammonton, [...]
Letter to Shareholders from CEO Dr. Ryan Saadi
06/03/2026
WARREN, N.J., March 06, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ). Dear Shareholders, As we continue executing on Tevogen’s long-term strategy to evolve into a [...]
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
06/03/2026
ZUG, Switzerland, March 06, 2026 (GLOBE NEWSWIRE) -- The attached notifications relate to the vesting and settlement of RSUs previously granted to directors of the Company. Attachments Notification of managers' [...]
Galapagos Creates New Subscription Right Plan
06/03/2026
Mechelen, Belgium; March 6, 2026, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its Board of Directors created 1,750,000 subscription rights under a new subscription [...]
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06/03/2026
CAMBRIDGE, Mass., March 06, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core [...]
Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds
06/03/2026
Dallas, TX, March 06, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine platform [...]
CardioGLYX Blood Balance Support Claims Evaluated: 2026 Consumer Report Examines Blood Sugar, Cholesterol and Metabolic Ingredient Research
06/03/2026
A 2026 informational consumer research report analyzing CardioGLYX Blood Support marketing claims, ingredient research context, pricing disclosures, and verification considerations for adults researching metabolic [...]
EssilorLuxottica: Mise à disposition du Document d’enregistrement universel 2025
06/03/2026
Mise à disposition du Document d’enregistrement universel 2025 Paris, France (6 mars 2026) – EssilorLuxottica annonce la mise à disposition de son Document d’enregistrement universel 2025 dans les conditions requises [...]
Nika Pharmaceuticals, Inc. (NIKA) Signed a Consultancy Agreement with MD Global Partners LLC
06/03/2026
HENDERSON, Nev., March 06, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: NIKA ) announces that it has signed a consultancy agreement with MD Global Partners LLC, a leading Manhattan-based investment bank. [...]
Informations relatives au nombre total de droits de vote et d’actions composant le capital
06/03/2026
Nantes, le 6 mars 2026 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement général de l’AMF, OSE Immunotherapeutics (ISIN : FR0012127173 ; Mnémo : OSE), société intégrée de [...]
EssilorLuxottica: 2025 Universal Registration Document filed
06/03/2026
2025 Universal Registration Document filed Paris, France (6 March 2026) – EssilorLuxottica announces the availability of its 2025 Universal Registration Document, in accordance with applicable regulation. The French [...]
VALNEVA Déclaration d’actions et de droits de vote : 28 février 2026
06/03/2026
VALNEVA Déclaration d’actions et de droits de vote 28 février 2026 __________________________________________________________________________________________ Dénomination sociale : VALNEVA Adresse du siège social : Îlot [...]

Pages